Immune cells and angiogenesis

Domenico Ribatti, Enrico Crivellato

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, through the production and release of a large spectrum of pro-angiogenic mediators. These may create the specific microenvironment that favours an increased rate of tissue vascularization. In this review, we will focus on the immune cell component of the angiogenic process in inflammation and tumour growth. As angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators, we will also provide information on some antiangiogenic properties of immune cells that may be utilized for a potential pharmacological use as antiangiogenic agents in inflammation as well as in cancer.

Original languageEnglish
Pages (from-to)2822-2833
Number of pages12
JournalJournal of Cellular and Molecular Medicine
Volume13
Issue number9 A
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Inflammation
Angiogenesis Inhibitors
Cellular Structures
Cell Movement
Neoplasms
Endothelial Cells
Cell Proliferation
Pharmacology
Growth

Keywords

  • Angiogenesis
  • Antiangiogenesis
  • Chronic inflammation
  • Immune cells
  • Tumour growth

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine

Cite this

Immune cells and angiogenesis. / Ribatti, Domenico; Crivellato, Enrico.

In: Journal of Cellular and Molecular Medicine, Vol. 13, No. 9 A, 09.2009, p. 2822-2833.

Research output: Contribution to journalArticle

Ribatti, Domenico ; Crivellato, Enrico. / Immune cells and angiogenesis. In: Journal of Cellular and Molecular Medicine. 2009 ; Vol. 13, No. 9 A. pp. 2822-2833.
@article{2d3605618be3483fa22409895b3e3985,
title = "Immune cells and angiogenesis",
abstract = "Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, through the production and release of a large spectrum of pro-angiogenic mediators. These may create the specific microenvironment that favours an increased rate of tissue vascularization. In this review, we will focus on the immune cell component of the angiogenic process in inflammation and tumour growth. As angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators, we will also provide information on some antiangiogenic properties of immune cells that may be utilized for a potential pharmacological use as antiangiogenic agents in inflammation as well as in cancer.",
keywords = "Angiogenesis, Antiangiogenesis, Chronic inflammation, Immune cells, Tumour growth",
author = "Domenico Ribatti and Enrico Crivellato",
year = "2009",
month = "9",
doi = "10.1111/j.1582-4934.2009.00810.x",
language = "English",
volume = "13",
pages = "2822--2833",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "9 A",

}

TY - JOUR

T1 - Immune cells and angiogenesis

AU - Ribatti, Domenico

AU - Crivellato, Enrico

PY - 2009/9

Y1 - 2009/9

N2 - Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, through the production and release of a large spectrum of pro-angiogenic mediators. These may create the specific microenvironment that favours an increased rate of tissue vascularization. In this review, we will focus on the immune cell component of the angiogenic process in inflammation and tumour growth. As angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators, we will also provide information on some antiangiogenic properties of immune cells that may be utilized for a potential pharmacological use as antiangiogenic agents in inflammation as well as in cancer.

AB - Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, through the production and release of a large spectrum of pro-angiogenic mediators. These may create the specific microenvironment that favours an increased rate of tissue vascularization. In this review, we will focus on the immune cell component of the angiogenic process in inflammation and tumour growth. As angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators, we will also provide information on some antiangiogenic properties of immune cells that may be utilized for a potential pharmacological use as antiangiogenic agents in inflammation as well as in cancer.

KW - Angiogenesis

KW - Antiangiogenesis

KW - Chronic inflammation

KW - Immune cells

KW - Tumour growth

UR - http://www.scopus.com/inward/record.url?scp=72849141569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72849141569&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2009.00810.x

DO - 10.1111/j.1582-4934.2009.00810.x

M3 - Article

C2 - 19538473

AN - SCOPUS:72849141569

VL - 13

SP - 2822

EP - 2833

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 9 A

ER -